Impact of Menstrual Cycle-Based Resistance Training on Neuromuscular Performance in Female Athletes
- Conditions
- Menstrual CycleResistance TrainingNeuromuscular FunctionFemale AthleteWomen HealthOral Contraceptive PillMuscle StrenghtHormonesPeriodized Training
- Registration Number
- NCT06679491
- Lead Sponsor
- Universite de La Reunion
- Brief Summary
The goal of this clinical trial is to assess the impact of menstrual cycle-based resistance training on neuromuscular function in female athletes.
The primary questions it aims to answer are :
* Does varying resistance training intensity according to menstrual phases improve maximal knee extensor strength?
* How do different training protocols affect voluntary activation, rate of force development, muscle stiffness, and vertical jump height?
Researchers will compare natural menstrual cycle groups with an oral contraceptive control group to determine if menstrual phase-specific training influences neuromuscular adaptations.
Participants will:
* Undergo 2 weekly resistance training sessions over 13 weeks with intensity adjustments based on menstrual phase
* Complete periodic neuromuscular assessments across three menstrual phases: early follicular, late follicular, and mid-luteal before and after resistance training intervention
- Detailed Description
This study investigates the neuromuscular effects of menstrual cycle-based resistance training by comparing three distinct training protocols among female athletes with natural menstrual cycles and a control group of athletes using oral contraceptives. Hormonal fluctuations across the menstrual phases can impact muscle performance, recovery, and neuromuscular function. This trial aims to align training intensity with menstrual cycle phases to enhance neuromuscular adaptations.
Study Design and Population
The trial is a controlled, randomized, open-label design involving 60 recreationally active female athletes aged 18 and above. Participants are allocated into four groups:
N-PF: Natural menstrual cycle with increased training intensity during the follicular phase.
N-PL: Natural menstrual cycle with increased training intensity during the luteal phase.
N-C: Natural menstrual cycle with continuous training intensity across all phases.
OCP-C: Oral contraceptive users with continuous training intensity. Each participant completes a 13-week resistance training program tailored to her group's specific phase-aligned training protocol, with two sessions per week. To assess the neuromuscular impact, we perform pre- and post-intervention evaluations across three key menstrual phases: early follicular, late follicular, and mid-luteal.
Neuromuscular Assessments Primary outcomes include maximal knee extensor strength, assessed through isokinetic testing, and secondary measures cover neuromuscular activation, rate of force development (RFD), muscle stiffness, and vertical jump performance (CMJ). These assessments are conducted during each of the three menstrual phases pre- and post-intervention to capture phase-specific neuromuscular adaptations. Blood sampling for hormonal verification (estradiol and progesterone levels) accompanies each phase-specific testing session.
Methodology and Rationale The training intensity and volume are adjusted based on the participant's menstrual phase to leverage hormonal benefits, with estrogen levels typically promoting muscular strength in the follicular phase and progesterone affecting endurance in the luteal phase. We hypothesize that phase-specific training may yield greater improvements in strength, muscle stiffness, and overall neuromuscular efficiency.
This study's findings are expected to provide novel insights into optimizing training loads for female athletes according to hormonal cycles, with implications for improving performance, reducing injury risk, and advancing individualized training and rehabilitation protocols.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- Female
- Target Recruitment
- 60
- Female athletes with natural menstrual cycles (eumenorrheic): Participants must have regular menstrual cycles lasting between 21 and 35 days, with at least 9 cycles per year.
- Women using a low-dose monophasic estrogen-progestin oral contraceptive.
- Age 18 or older: Participants must be legal adults.
- Body Mass Index (BMI) between 18 and 30 kg/m².
- No medical contraindications to high-level physical training or exercise.
- Physically active: Engages in at least 3 hours of physical activity per week.
- Informed consent: Provides written, informed consent to participate in the study.
- Affiliation with a social security system (if applicable by local regulations).
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Maximal knee extensor strenght From baseline assessment prior to intervention to post-intervention at 13 weeks. Description:
This outcome measure assesses the maximal isokinetic strength of the knee extensor muscles, measured as peak torque (rotational force) in Newton-meters (Nm), using an isokinetic dynamometer.
Scoring and Interpretation:
Higher scores indicate greater strength, with no theoretical upper limit as scores are determined by the individual's maximal voluntary contraction.
Typical Range: In athletic populations, peak torque values generally range from 100 to 250 Nm, but individual results may vary based on factors like muscle size and training status.
Criteria for Change: An improvement in peak torque post-intervention indicates a positive neuromuscular adaptation to the training program.
This measure quantifies changes in lower limb strength over time, allowing comparison of neuromuscular adaptations between menstrual phase-aligned and continuous training groups.
- Secondary Outcome Measures
Name Time Method Rate of Force Development (RFD) From baseline assessment prior to intervention to post-intervention at 13 weeks Evaluates the speed at which force is generated by the knee extensor muscles. This is a key indicator of explosive strength, relevant for sports performance.
Measurement: Calculated as the slope of the force-time curve from the onset of muscle contraction.
Relevance: Higher RFD values suggest improved neuromuscular response and power output.Active muscle stiffness From baseline assessment prior to intervention to post-intervention at 13 weeks. Measures the active stiffness of the knee extensor muscles during before and after a fatiguing task, at 50%MVC with a shear wave elastrography (SWE) methods.
Voluntary Muscle Activation (%AV) From baseline assessment prior to intervention to post-intervention at 13 weeks. Description: Assesses the degree of maximal voluntary activation in the knee extensor muscles before, during and after an "all-out" effort. This test captures the participant's capacity to recruit motor units fully, measured using twitch interpolation technique to evaluate the difference between voluntary and stimulated muscle force output.
Relevance: This measure reflects the participant's neuromuscular efficiency by indicating their ability to achieve maximal muscle activation without additional external stimulation. It provides insight into central nervous system drive and the efficiency of motor unit recruitment during intense exertion.Vertical Jump Height (Countermovement Jump - CMJ) From baseline assessment prior to intervention to post-intervention at 13 weeks. Measures the maximal height achieved during a countermovement jump, recorded as a functional measure of lower body power. Relevance: Vertical jump height reflects overall lower limb strength and power, providing insight into functional athletic performance.
Trial Locations
- Locations (1)
Laboratoire IRISSE (Université de La Réunion)
🇷🇪Le Tampon, France, Réunion